Upstream Processing

Apr 01, 2015
BioPharm International
Making the switch from batch to continuous manufacturing requires a thorough understanding of the process.
Mar 01, 2015
BioPharm International
It is important to understand degradation and processing to maintain product stability in biologics.
Feb 01, 2015
BioPharm International
The use of commercially available media to achieve high titer in early process development is discussed.
Feb 01, 2015
BioPharm International
They may not be glamorous, but buffers play an important role in biopharma manufacturing.
Jan 20, 2015
BioPharm International
Catalent announced that it would partner with Mitsubishi Gas Chemical Company, and its subsidiary MGC Pharma, to promote GPEx technology, a high-titer vector for stable mammalian cell lines.
Jan 09, 2015
By BioPharm International Editors
Single-use components will be used in automated personalized therapy manufacturing.
Jan 01, 2015
BioPharm International
Improving efficiency, value chain, quality, and protein complexity with advanced bioprocess development.
Dec 23, 2014
By BioPharm International Editors
Protein Sciences will evaluate sourcing Flublok from its Japanese licensee, UMN Pharma, which already runs a large-scale facility for the vaccine.
Dec 19, 2014
By BioPharm International Editors
The Cell Therapy Catapult, a UK non-profit center for advancing cell and gene therapies, will manage the manufacturing center, which will be used for late-phase clinical trials and commercial supply.
native1_300x100
lorem ipsum